Brain Changes in Stimulant Dependent Subjects - 8
This trial has been completed.
|Sponsor||National Institute on Drug Abuse (NIDA)|
|Start date||April 1996|
|Trial size||90 participants|
|Trial identifier||NCT00000343, NIDA-3-0010-8, Y01-3-0010-8|
The purpose of this study is to identify the neurophysiologic indicators of cocaine or methamphetamine use and withdrawal, to examine the relationship between subjects' reports of depression, craving, and stimulant use, and neurophysiologic measures, and to identify neurophysiologic measures which can be used to identify new treatments for stimulant dependence.
All participants from 21 years up to 50 years old.
Inclusion Criteria: M/F ages 21-50. Meet DSM-IV criteria for cocaine dependence. Agree to conditions of the study and sign informed consent. Exclusion Criteria: Psychiatric disorder that requires medication therapy. History of seizures. Pregnant and/or nursing women. Dependence on ETOH or benzodiazepines or other sedative/hypnotics. Acute hepatitis. Other medical conditions that deem participation to be unsafe.
|Official title||Brain Changes in Stimulant Dependent Subjects|
|Principal investigator||Walter Ling, M.D.|
|Description||By Incorporating QEEG into clinical trails, the plan is to develop physiologic markers of treatment efficacy, and to aid in the identification of effective treatments.|
Call for more information